RS
VIVO

Robeco Schweiz’s Meridian Bioscience Inc VIVO Stock Holding History

Robeco Schweiz’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,400
Closed -$435K – 162
2018
Q4 		$435K Buy
25,400
+15,100
+147% +$258K 0.02% 137
2018
Q3 		$153K Buy
10,300
+6,800
+194% +$105K 0.01% 157
2018
Q2 		$56K Buy
3,500
+1,241
+55% +$18.5K ﹤0.01% 173
2018
Q1 		$32K Sell
2,259
-2,475
-52% -$36.6K ﹤0.01% 176
2017
Q4 		$67K Buy
+4,734
New +$69.3K ﹤0.01% 170

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Robeco Schweiz's VIVO Position: Q1 2019 in Review

Robeco Schweiz sold out of Meridian Bioscience Inc (VIVO) in Q1 2019, closing a stake of 25,400 shares — an estimated $435K sold.

Robeco Schweiz first reported a position in VIVO in Q4 2017 and held it in 5 quarters. The position peaked at $435K in Q4 2018. 183 funds tracked by Wall St. Rank hold VIVO as of Q1 2019.

  • Robeco Schweiz reported no remaining Meridian Bioscience Inc position as of Q1 2019 after selling out during the quarter.
  • Robeco Schweiz sold 25,400 Meridian Bioscience Inc shares in Q1 2019, an estimated $435K.
  • Robeco Schweiz first reported a position in Meridian Bioscience Inc in Q4 2017 and held it in 5 quarters.
  • Robeco Schweiz's Meridian Bioscience Inc position peaked at $435K in Q4 2018.
  • 183 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2019.

Based on Robeco Schweiz's 13F filing for Q1 2019, filed 14 May 2019.